Jennifer Fitzpatrick
Chief Legal Officer Sionna Therapeutics
Seminars
Wednesday 5th August 2026
Panel Discussion: Strengthening IPO Readiness to Reduce Liability Exposure & Support Defensible Board Decision‑Making
3:15 pm
- Build disclosure discipline early by aligning scientific claims, press releases, BD decks, and public statements to withstand S‑1 scrutiny
- Reduce litigation and enforcement risk through structured risk‑factor design and clear escalation controls
- Strengthen Board decision‑making with disciplined go/no‑go criteria, documentation standards, and scenario pathways
Wednesday 5th August 2026
Panel Discussion: Building Stage Appropriate Compliance Foundations to Strengthen Development to Commercial Readiness
1:30 pm
- Understand the core compliance infrastructure required at each stage of development, allowing you to anticipate obligations and minimize maturity gaps as programs advance
- Compare how Legal versus Compliance build and own early compliance foundations in small companies, clarifying operating models, decision rights, and how different organizations divide responsibilities on the road to commercial readiness.
- Leave with a clear, stage-based roadmap outlining what must be in place early, what should evolve over time and what must rapidly scale ahead of commercial launch
